- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.90 Å
- Oligo State
- hetero-2-2-2-2-2-2-2-2-2-2-2-2-2-2-mer
- Ligands
- 41 x CL: CHLORIDE ION(Non-functional Binders)
- 13 x K: POTASSIUM ION(Non-covalent)(Non-functional Binders)
K.4: 1 residues within 4Å:- Chain B: H.142
No protein-ligand interaction detected (PLIP)K.7: 2 residues within 4Å:- Chain G: Y.159, Y.160
No protein-ligand interaction detected (PLIP)K.12: 6 residues within 4Å:- Chain B: L.99, Q.100
- Chain I: Q.65
- Chain J: N.82, R.85, R.86
No protein-ligand interaction detected (PLIP)K.16: 4 residues within 4Å:- Chain K: N.38, C.63, R.64, Y.67
1 PLIP interactions:1 interactions with chain K- Metal complexes: K:C.63
K.19: 4 residues within 4Å:- Chain L: R.211, D.213
- Chain V: K.29, G.171
No protein-ligand interaction detected (PLIP)K.24: 0 residues within 4Å:- (No contacts)
No protein-ligand interaction detected (PLIP)K.40: 4 residues within 4Å:- Chain R: N.13
- Chain S: N.8, D.9, R.125
No protein-ligand interaction detected (PLIP)K.52: 1 residues within 4Å:- Ligands: CL.51
No protein-ligand interaction detected (PLIP)K.56: 0 residues within 4Å:- (No contacts)
No protein-ligand interaction detected (PLIP)K.57: 0 residues within 4Å:- (No contacts)
No protein-ligand interaction detected (PLIP)K.58: 1 residues within 4Å:- Chain Z: S.93
2 PLIP interactions:1 interactions with chain Z, 1 Ligand-Water interactions- Metal complexes: Z:S.93, H2O.34
K.63: 5 residues within 4Å:- Chain 0: D.25, M.173, L.176, S.183, Y.184
No protein-ligand interaction detected (PLIP)K.66: 5 residues within 4Å:- Chain 1: R.19, D.166, S.169
- Chain M: A.181, S.183
No protein-ligand interaction detected (PLIP)- 6 x 04C: 1,2,4-trideoxy-4-methyl-2-{[N-(morpholin-4-ylacetyl)-L-alanyl-O-methyl-L-tyrosyl]amino}-1-phenyl-D-xylitol(Covalent)
04C.8: 18 residues within 4Å:- Chain H: T.1, R.19, A.20, T.21, N.22, C.31, K.33, G.45, G.47, V.48, A.49, T.52, E.53, S.129, G.168
- Chain I: D.125, I.127
- Ligands: IOD.9
14 PLIP interactions:12 interactions with chain H, 2 interactions with chain I- Hydrophobic interactions: H:T.21, H:K.33, H:V.48, H:A.49
- Hydrogen bonds: H:T.21, H:T.21, H:G.47, H:G.47, H:G.47, H:A.49, H:S.129, I:D.125
- Water bridges: H:D.23
- Salt bridges: I:D.125
04C.14: 15 residues within 4Å:- Chain K: T.1, R.19, A.20, T.21, M.31, K.33, M.45, G.47, C.48, A.49, S.96, Y.169
- Chain L: D.125
- Ligands: IOD.15, CL.18
12 PLIP interactions:10 interactions with chain K, 2 interactions with chain L- Hydrophobic interactions: K:M.45, K:A.49
- Hydrogen bonds: K:T.1, K:T.21, K:T.21, K:T.21, K:G.47, K:G.47, K:G.47, K:A.49, L:D.125, L:D.125
04C.25: 17 residues within 4Å:- Chain H: H.116, S.118
- Chain N: T.1, R.19, V.20, S.21, A.22, F.31, K.33, L.45, S.46, G.47, S.48, A.49, L.95, S.168
- Ligands: IOD.26
12 PLIP interactions:11 interactions with chain N, 1 interactions with chain H- Hydrophobic interactions: N:V.20, N:F.31, N:L.45, N:L.45, N:A.49
- Hydrogen bonds: N:S.21, N:S.21, N:S.21, N:G.47, N:G.47, N:A.49
- Water bridges: H:S.118
04C.42: 19 residues within 4Å:- Chain V: T.1, R.19, A.20, T.21, N.22, C.31, K.33, G.45, A.46, G.47, V.48, A.49, T.52, E.53, S.129, G.168
- Chain W: D.125, I.127
- Ligands: IOD.43
13 PLIP interactions:11 interactions with chain V, 2 interactions with chain W- Hydrophobic interactions: V:A.20, V:T.21, V:V.48, V:A.49
- Hydrogen bonds: V:T.21, V:T.21, V:G.47, V:G.47, V:G.47, V:A.49, V:S.129, W:D.125
- Salt bridges: W:D.125
04C.53: 14 residues within 4Å:- Chain Y: T.1, R.19, A.20, T.21, M.31, K.33, M.45, G.47, C.48, A.49, Y.169
- Chain Z: D.125, P.126
- Ligands: IOD.54
9 PLIP interactions:1 interactions with chain Z, 8 interactions with chain Y- Hydrogen bonds: Z:D.125, Y:T.21, Y:T.21, Y:G.47, Y:G.47, Y:G.47, Y:A.49
- Hydrophobic interactions: Y:M.45, Y:A.49
04C.64: 17 residues within 4Å:- Chain 1: T.1, R.19, V.20, S.21, F.31, K.33, L.45, S.46, G.47, S.48, A.49, A.52, L.95, S.168
- Chain V: H.116, S.118
- Ligands: IOD.65
12 PLIP interactions:12 interactions with chain 1- Hydrophobic interactions: 1:V.20, 1:F.31, 1:L.45, 1:L.45, 1:A.49, 1:A.52
- Hydrogen bonds: 1:S.21, 1:S.21, 1:S.21, 1:G.47, 1:G.47, 1:A.49
- 6 x IOD: IODIDE ION(Non-functional Binders)
IOD.9: 3 residues within 4Å:- Chain H: G.47, S.129
- Ligands: 04C.8
Ligand excluded by PLIPIOD.15: 3 residues within 4Å:- Chain K: S.46, G.47
- Ligands: 04C.14
Ligand excluded by PLIPIOD.26: 3 residues within 4Å:- Chain N: G.47, S.129
- Ligands: 04C.25
Ligand excluded by PLIPIOD.43: 3 residues within 4Å:- Chain V: G.47, S.129
- Ligands: 04C.42
Ligand excluded by PLIPIOD.54: 3 residues within 4Å:- Chain Y: S.46, G.47
- Ligands: 04C.53
Ligand excluded by PLIPIOD.65: 3 residues within 4Å:- Chain 1: G.47, S.129
- Ligands: 04C.64
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Huber, E.M. et al., Immuno- and constitutive proteasome crystal structures reveal differences in substrate and inhibitor specificity. Cell(Cambridge,Mass.) (2012)
- Release Date
- 2012-02-29
- Peptides
- Proteasome subunit alpha type-2: AO
Proteasome subunit alpha type-4: BP
Proteasome subunit alpha type-7: CQ
Proteasome subunit alpha type-5: DR
Proteasome subunit alpha type-1: ES
Proteasome subunit alpha type-3: FT
Proteasome subunit alpha type-6: GU
Proteasome subunit beta type-10: HV
Proteasome subunit beta type-3: IW
Proteasome subunit beta type-2: JX
Proteasome subunit beta type-8: KY
Proteasome subunit beta type-1: LZ
Proteasome subunit beta type-4: M0
Proteasome subunit beta type-9: N1 - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AO
OB
BP
PC
CQ
QD
DR
RE
ES
SF
FT
TG
GU
UH
HV
VI
IW
WJ
JX
XK
KY
YL
LZ
ZM
M0
aN
N1
b
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.90 Å
- Oligo State
- hetero-2-2-2-2-2-2-2-2-2-2-2-2-2-2-mer
- Ligands
- 41 x CL: CHLORIDE ION(Non-functional Binders)
- 13 x K: POTASSIUM ION(Non-covalent)(Non-functional Binders)
- 6 x 04C: 1,2,4-trideoxy-4-methyl-2-{[N-(morpholin-4-ylacetyl)-L-alanyl-O-methyl-L-tyrosyl]amino}-1-phenyl-D-xylitol(Covalent)
- 6 x IOD: IODIDE ION(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Huber, E.M. et al., Immuno- and constitutive proteasome crystal structures reveal differences in substrate and inhibitor specificity. Cell(Cambridge,Mass.) (2012)
- Release Date
- 2012-02-29
- Peptides
- Proteasome subunit alpha type-2: AO
Proteasome subunit alpha type-4: BP
Proteasome subunit alpha type-7: CQ
Proteasome subunit alpha type-5: DR
Proteasome subunit alpha type-1: ES
Proteasome subunit alpha type-3: FT
Proteasome subunit alpha type-6: GU
Proteasome subunit beta type-10: HV
Proteasome subunit beta type-3: IW
Proteasome subunit beta type-2: JX
Proteasome subunit beta type-8: KY
Proteasome subunit beta type-1: LZ
Proteasome subunit beta type-4: M0
Proteasome subunit beta type-9: N1 - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AO
OB
BP
PC
CQ
QD
DR
RE
ES
SF
FT
TG
GU
UH
HV
VI
IW
WJ
JX
XK
KY
YL
LZ
ZM
M0
aN
N1
b